RDC 669/2022
Minimum requirements to ensure the quality of imported biological products
Current edition
RDC 669 of March 30, 2022, in force since May 2, 2022
Current edition
RDC 669 of March 30, 2022, in force since May 2, 2022
About this standard
Recognition by market
Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts
No market listing is published yet.
Testing requirements that cite it
Open the market page and its pathway pages for the full requirement, protocol and report content
Brazil
- Quality control in Brazil of imported batches of biological products by the registration holderLot release and sample testing · Local test (some cases)
Related standards: MHRA Responsible Person (import) guidance, EudraLex Volume 4 Annex 16, HC Lot Release Program guidance, TGA vaccine batch release, MFDS imported drug management regulation, MFDS national lot release regulation, RDC 670/2022, RDC 900/2024, RDC 944/2024, SFDA lot release policy, Taiwan biological product lot release regulations. See all standards.